Better Context Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.

sanofi cover image
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, GLP-1RA + Basal Dec 12 | 2019Would AZ, Teva, or Mylan/Upjohn Buy Sanofi's DCV Business?Purchase Blast
$599
Posted in: Basal Insulin, Glucagon, Glucose Monitoring, Insulin Delivery Dec 11 | 2019Xeris Positive Ph2 Data in PBH; Oramed Partnership with Tianhui; Glooko Privacy Shield CertificationPurchase Blast
sanofi cover image
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, Glucose Monitoring, Insulin Delivery, Other Dec 10 | 2019Sanofi To Move Away From Diabetes/CV; Sanofi 2019 Capital Markets DayPurchase Blast
european medicines agency cover image
$599
Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, GLP-1RA Dec 09 | 2019High-Dose Trulicity Filed in EU (CHMP Agenda December 9-12)Purchase Blast
lilly cover image
$599
Posted in: Dual/triple agonist, GLP-1RA Dec 04 | 2019Tirzepatide Ph3 Obesity Program Initiated (SURMOUNT-1)Purchase Blast
$599
Posted in: Glucose Monitoring Nov 25 | 2019Dario Expands Retail Presence For Connected BGMPurchase Blast
1 2 3 32

Get the Latest Analysis

Stay informed and aligned with frequent updates to keep a pulse on the industry.

If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.